Hepatoprotective Effect of Lactiplantibacillus plantarum DSR330 in Mice with High Fat Diet-Induced Nonalcoholic Fatty Liver Disease

키워드

참고문헌 (34)

1. Samuel VT, "Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases", Cell Metab, 27, pp.22~41 (2018)
2. Hyun J, "Kombucha tea prevents obese mice from developing hepatic steatosis and liver damage", Food Sci. Biotechnol, 25, pp.861~866 (2016)
3. Michelotti GA, "NAFLD, NASH and liver cancer", Nat. Rev. Gastroenterol. Hepatol, 10, pp.656~665 (2018)
4. Durazno M, "Focus on therapeutic strategies of nonalcoholic fatty liver disease", Int. J. Hepatol, 2012, pp.464706~ (2012)
5. Carling D, "AMP-activated protein kinase : new regulation, new roles?", Biochem. J, 445, pp.11~27 (2012)
6. Viollet B, "AMP-activated protein kinase in the regulation of hepatic energy metabolism : from physiology to therapeutic perspectives", Acta Physiol, 196, pp.81~98 (2009)
7. Moslehi A, "Role of SREBPs in liver diseases : a mini-review", J. Clin. Transl. Hepatol, 6, pp.332~338 (2018)
8. Smith BK, "Treatment of nonalcoholic fatty liver disease : role of AMPK", Am. J. Physiol. Endocrinol. Metab, 311, pp.E730~E740 (2016)
9. Assifi MM, "AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved", carbohydrate-refed rats, 2005, pp.289, E794~E800
10. Foretz M, "AMPK activation reduces hepatic lipid content by increasing fat oxidation in vivo", Int. J. Mol. Sci, 19, pp.2826~ (2018)
11. Choi DJ, "Protective effect of a mixture of Astragalus membranaceus and Lithospermum erythrothizon extract against hepatic steatosis in high fat diet-induced nonalcoholic fatty liver disease mice", Evid. Based Complement. Altern. Med, 2020, pp.8370698~ (2020)
12. Lee NK, "Paraprobiotics : definition, manufacturing methods, and functionality", Food Sci. Biotechnol, 32, pp.1981~1991 (2023)
13. Hyun JH, "Anti-inflammatory activities of Levilactobacillus brevis KU15147 in RAW 264.7 cells stimulated with lipopolysaccharide on attenuating NF-κB, AP-1, and MAPK signaling pathways", Food Sci. Biotechnol, 32, pp.2105~1991 (2023)
14. Kim WJ, "Protective effect of a novel Lactobacillus brevis strain with probiotic characteristics against Staphylococcus aureus lipoteichoic acid–induced intestinal inflammatory response", J. Microbiol. Biotechnol, 32, pp.205~211 (2022)
15. Huang Y, "Effect of probiotics therapy on nonalcoholic fatty liver disease", Comput. Math Methods Med, 2022, pp.7888076~ (2022)
16. Velayudham A, "VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice", Hepatology, 49, pp.989~997 (2009)
17. Cao F, "Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota", Front. Nutr, 9, pp.1071284~ (2022)
18. Sun M, "Lactobacillus rhamnosus LRa05 improves lipid accumulation in mice fed with a high fat diet via regulating the intestinal microbiota, reducing glucose content and promoting liver carbohydrate metabolism", Food Funct, 11, pp.9514~9525 (2020)
19. Wu T, "Lactobacillus rhamnosus LRa05 ameliorate hyperglycemia through a regulating glucagon-mediated signaling pathway and gut microbiota in type 2 diabetic mice", J. Agric. Food Chem, 69, pp.8797~8806 (2021)
20. Ryu BH, "Novel Lactobacillus plantarum from kimchi with inhibiting activities on pathogenic microorganism and use thereof", Patent. KR101485182B1, ~ (2007)
21. Chang BY, "Tricin-enriched Zizania latifolia ameliorates non-alcoholic fatty liver disease through AMPK-dependent pathways", Food Sci. Biotechnol, 32, pp.2117~2129 (2023)
22. Mashek DG, "Hepatic lipid droplets : a balancing act between energy storage and metabolic dysfunction in NAFLD", Mol. Metab, 50, pp.101115~ (2020)
23. Meroni M, "The role of probiotics nonalcoholic fatty liver disease : a new insight into therapeutic strategies", Nutrients, 11, pp.2642~ (2019)
24. Park SY, "Anti-obesity potential through regulation of carbohydrate uptake and gene expression in intestinal epithelial cells by the probiotics Lactiplantibacillus plantarum MGEL20154 from fermented food", J. Microbiol. Biotechnol, 33, pp.621~633 (2023)
25. Polyzos SA, "Obesity and nonalcoholic fatty liver disease : from pathophysiology to therapeutics", Metabolism, 92, pp.82~97 (2019)
26. Kim JW, "Anti-obesity and fatty liver-preventing activities of Lonicera caerulea in high-fat diet-fed mice", Int. J. Mol. Med, 42, pp.3047~3064 (2018)
27. Hadizadeh F, "Nonalcoholic fatty liver disease : diagnostic biomarkers", World Gastrointest. Pathophysiol, 15, pp.11~26 (2017)
28. Draijer L, "Pediatric NAFLD : an overview and recent developments in diagnostics and treatment", Expert Rev. Gastrolenterol. Hepatol, 13, pp.447~461 (2019)
29. Fang C, "The AMPK pathway in fatty liver disease", Front. Physiol, 13, pp.970292~ (2022)
30. Moslehi A, "Role of SREBPs in liver diseases : a mini-review", J. Clin. Transl. Hepatol, 6, pp.332~338 (2018)
31. Kim HI, "Lactobacillus plantarum LC27 and Bifidobacterium longum LC67simultaneously alleviated HFD-induced colitis, endotoxemia, liver steatosis, and obesity in mice", Nutr. Res, 67, pp.78~89 (2019)
32. Lee E, "Lactobacillus plantarum strain Ln4 attenuates diet-induced obesity, insulin resistance, and changes in hepatic mRNA levels associated with glucose and lipid metabolism", Nutrients, 10, pp.643~ (2018)
33. Bauche IB, "Overexpression of adiponectin targeted to adipose tissue in transgenic mice : Impaired adipocyte differentiation", Endocrinology, 148, pp.1539~1549 (2007)
34. Fabbrini E, "Hepatic steatosis as a marker of metabolic dysfunction", Nutrients, 7, pp.4995~5019 (2015)

관련 논문AI추천